我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 安全点亮
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • ICMJE
分享此页面

抽象的

The Regulatory Action of Fibro fog: Pain, Quality of Life, Sleep, Anxiety and Depression observed after 42 Months of Treatment: A Case Report

Laser; Ultrasound; Sleep; Fibro fog; Anxiey; Depression

Fibromyalgia is a chronic syndrome that acts on the musculoskeletal system, causing disabling pain, in addition to many other symptoms. As one of the associated symptoms, there are cognitive changes, such as difficulty maintaining concentration and memory, known as Fibrofog. The difficulties imposed by cognitive dysfunctions can change the lives of patients with fibromyalgia, affecting family, professional life and social interaction. As a treatment for fibromyalgia, the combined use of laser and ultrasound has been of great value, reducing pain and improving quality of life. The present study followed a patient affected by fibromyalgia for 42 months after treatment with laser and ultrasound, quantifying questionnaires and scales: Visual Analogue Scale, Fibromyalgia Impact Questionnaire, Pittsburgh Sleep Quality Index, Hospital Anxiety and Depression Scale and Beck Depression Inventory – II. The results point to a reduction of over 90% for the improvement of the evaluated conditions of pain, quality of life, sleep, anxiety and depression, ending with the report of improvement in Fibrofog, where the patient, after treatment, started her graduation in physiotherapy. We conclude that the methodology employed, using the synergism of Laser and ultrasound, although it points to the improvement of Fibrofog in a case report, is widely used in the treatment of fibromyalgia for pain control, allowing new follow-ups to be carried out.